U.K. biopharma stocks weather the Brexit storm

U.K. biopharma stocks held steady Thursday despite the turmoil caused by Brexit negotiations, while the pound lost almost 2% of its value.

AstraZeneca plc (LSE:AZN; NYSE:AZN) stock was unchanged in New York on Thursday, and rose 44p to 6,317p in

Read the full 395 word article

User Sign In